Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo

Ann Bond, Nicole M. Jones, Caroline A. Hicks, Gary M. Whiffin, Mark A. Ward, Michael F. O'Neill, Ann E. Kingston, James A. Monn, Paul L. Ornstein, Darryle D. Schoepp, David Lodge and Michael J. O'Neill
Journal of Pharmacology and Experimental Therapeutics September 2000, 294 (3) 800-809;
Ann Bond
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole M. Jones
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline A. Hicks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary M. Whiffin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark A. Ward
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael F. O'Neill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann E. Kingston
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James A. Monn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Ornstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darryle D. Schoepp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lodge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. O'Neill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 294 no. 3 800-809
PubMed 
10945827

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received February 17, 2000
  • Accepted April 27, 2000
  • Published online September 1, 2000.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Ann Bond1,
  2. Nicole M. Jones2,
  3. Caroline A. Hicks1,
  4. Gary M. Whiffin1,
  5. Mark A. Ward1,
  6. Michael F. O'Neill1,
  7. Ann E. Kingston2,
  8. James A. Monn2,
  9. Paul L. Ornstein2,
  10. Darryle D. Schoepp2,
  11. David Lodge2 and
  12. Michael J. O'Neill1
  1. 1Eli Lilly & Co. Ltd., Lilly Research Centre, Windlesham, Surrey, United Kingdom (A.B., C.A.H., G.M.W., M.A.W., M.F.O., M.J.O.); and 2Eli Lilly & Co. Ltd., Lilly Corporate Center, Indianapolis, Indiana (N.M.J., A.E.K., J.A.M., P.L.O., D.D.S., D.L.)
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2000 to August 2022

    AbstractFullPdf
    Aug 2000562889
    Sep 2000204247
    Oct 2000112763
    Nov 200042927
    Dec 20004115
    Jan 200112411
    Feb 20014910
    Mar 200111616
    Apr 200101110
    May 20014228
    Jun 20014209
    Jul 2001268
    Aug 200111612
    Sep 2001058
    Oct 200131317
    Nov 20011810
    Dec 20010138
    Jan 200211219
    Feb 20021714
    Mar 20021910
    Apr 2002079
    May 2002177
    Jun 200221113
    Jul 200201712
    Aug 200211628
    Sep 200201412
    Oct 2002137
    Nov 200211914
    Dec 20021912
    Jan 200342117
    Feb 200301013
    Mar 200301112
    Apr 2003042
    May 2003076
    Jun 200311313
    Jul 200394019
    Aug 2003112617
    Sep 200381913
    Oct 20032485089
    Nov 2003265726
    Dec 200372927
    Jan 2004113014
    Feb 20049195
    Mar 2004133514
    Apr 2004113414
    May 2004204011
    Jun 200418307
    Jul 2004203410
    Aug 2004163211
    Sep 2004152814
    Oct 200415275
    Nov 200411226
    Dec 2004192212
    Jan 2005195217
    Feb 20058172
    Mar 2005132914
    Apr 20050123
    May 20054144
    Jun 200592112
    Jul 20054156
    Aug 200541413
    Sep 20053227
    Oct 20056226
    Nov 20056113
    Dec 2005195
    Jan 200622813
    Feb 20063138
    Mar 200632115
    Apr 200611188
    May 200641511
    Jun 20062118
    Jul 2006172
    Aug 2006245
    Sep 20066177
    Oct 20064811
    Nov 20063168
    Dec 200682213
    Jan 20075106
    Feb 20078169
    Mar 2007101621
    Apr 200791512
    May 2007673
    Jun 200761112
    Jul 200792222
    Aug 20077810
    Sep 20078166
    Oct 2007143818
    Nov 2007101211
    Dec 20070147
    Jan 2008111310
    Feb 2008111418
    Mar 2008191412
    Apr 20082376
    May 200831139
    Jun 2008172321
    Jul 2008192024
    Aug 20081395
    Sep 20082556
    Oct 2008261514
    Nov 200841278
    Dec 20081589
    Jan 2009161213
    Feb 20091279
    Mar 200921118
    Apr 2009361016
    May 200917810
    Jun 2009161916
    Jul 2009211511
    Aug 2009121910
    Sep 20092383
    Oct 20091778
    Nov 20092183
    Dec 20091231
    Jan 20102556
    Feb 20101375
    Mar 20101857
    Apr 2010765
    May 2010954
    Jun 2010698
    Jul 201011610
    Aug 20101077
    Sep 2010955
    Oct 201011716
    Nov 20101185
    Dec 2010555
    Jan 20111045
    Feb 2011484
    Mar 2011876
    Apr 20111147
    May 2011141016
    Jun 20111097
    Jul 2011181018
    Aug 2011161710
    Sep 201116911
    Oct 201114818
    Nov 2011161212
    Dec 201111914
    Jan 20121699
    Feb 201214319
    Mar 2012221214
    Apr 201211109
    May 201217314
    Jun 201210913
    Jul 2012191719
    Aug 201211419
    Sep 2012131216
    Oct 201226312
    Nov 201219118
    Dec 201218510
    Jan 201314714
    Feb 201324513
    Mar 201371215
    Apr 20132443
    May 201314916
    Jun 2013632
    Jul 2013967
    Aug 2013948
    Sep 20131354
    Oct 2013834
    Nov 20131562
    Dec 20131084
    Jan 20141762
    Feb 2014356
    Mar 20146812
    Apr 20141367
    May 2014376
    Jun 2014562
    Jul 20148156
    Aug 2014775
    Sep 2014252
    Oct 2014285
    Nov 2014113
    Dec 2014324
    Jan 201514118
    Feb 20154107
    Mar 2015762
    Apr 20152365
    May 2015768
    Jun 2015596
    Jul 20158510
    Aug 20151123
    Sep 20151395
    Oct 2015956
    Nov 2015486
    Dec 20155137
    Jan 2016425
    Feb 2016398
    Mar 20165413
    Apr 20164104
    May 20166237
    Jun 20169611
    Jul 20160219
    Aug 20160111
    Sep 20164916
    Oct 20161126
    Nov 20165107
    Dec 20160112
    Jan 20170137
    Feb 20170116
    Mar 20170154
    Apr 2017484
    May 2017761
    Jun 2017372
    Jul 20174103
    Aug 20175111
    Sep 2017395
    Oct 2017475
    Nov 2017277
    Dec 2017694
    Jan 20184111
    Feb 2018144
    Mar 2018462
    Apr 2018374
    May 2018296
    Jun 20184113
    Jul 20180144
    Aug 2018183
    Sep 2018446
    Oct 2018182
    Nov 2018255
    Dec 2018420
    Jan 2019930
    Feb 2019310
    Mar 2019662
    Apr 2019300
    May 2019830
    Jun 20192211
    Jul 2019900
    Aug 20191100
    Sep 20192833
    Oct 20191510
    Nov 20193253
    Dec 2019921
    Jan 2020722
    Feb 20201220
    Mar 2020610
    Apr 2020400
    May 2020700
    Jun 20201222
    Jul 2020500
    Aug 20202524
    Sep 2020541
    Oct 2020500
    Nov 2020830
    Dec 20201000
    Jan 20211531
    Feb 2021940
    Mar 20211131
    Apr 20211300
    May 2021940
    Jun 20211560
    Jul 2021920
    Aug 2021510
    Sep 2021240
    Oct 20211710
    Nov 20211900
    Dec 20211930
    Jan 2022510
    Feb 2022310
    Mar 20221111
    Apr 20221610
    May 2022620
    Jun 20221341
    Jul 20222130
    Aug 2022500

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics: 294 (3)
    Journal of Pharmacology and Experimental Therapeutics
    Vol. 294, Issue 3
    1 Sep 2000
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleNEUROPHARMACOLOGY

    Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo

    Ann Bond, Nicole M. Jones, Caroline A. Hicks, Gary M. Whiffin, Mark A. Ward, Michael F. O'Neill, Ann E. Kingston, James A. Monn, Paul L. Ornstein, Darryle D. Schoepp, David Lodge and Michael J. O'Neill
    Journal of Pharmacology and Experimental Therapeutics September 1, 2000, 294 (3) 800-809;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleNEUROPHARMACOLOGY

    Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo

    Ann Bond, Nicole M. Jones, Caroline A. Hicks, Gary M. Whiffin, Mark A. Ward, Michael F. O'Neill, Ann E. Kingston, James A. Monn, Paul L. Ornstein, Darryle D. Schoepp, David Lodge and Michael J. O'Neill
    Journal of Pharmacology and Experimental Therapeutics September 1, 2000, 294 (3) 800-809;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Glycine receptor modulation using monoclonal antibodies
    • Iclepertin (BI 425809) in Schizophrenia-Related Models
    • D1 Agonist Versus Methylphenidate on PFC Working Memory
    Show more Neuropharmacology

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics